Good Cop, Bad Cop: Profiling the Immune Landscape in Multiple Myeloma

NS Sharma, B Choudhary - Biomolecules, 2023 - mdpi.com
Multiple myeloma (MM) is a dyscrasia of plasma cells (PCs) characterized by abnormal
immunoglobulin (Ig) production. The disease remains incurable due to a multitude of …

Functional and molecular MRI of the bone marrow in multiple myeloma

V Koutoulidis, N Papanikolaou… - The British journal of …, 2018 - academic.oup.com
MRI plays an important role in the management of patients with plasma cell neoplasms and
has been recognized as a biomarker of malignancy in the novel criteria for the diagnosis of …

Differentiating diffuse from focal pattern on Computed Tomography in multiple myeloma: Added value of a Radiomics approach

AS Tagliafico, M Cea, F Rossi, F Valdora… - European journal of …, 2019 - Elsevier
Purpose Focal pattern in multiple myeloma (MM) seems to be related to poorer survival and
differentiation from diffuse to focal pattern on computed tomography (CT) has inter-reader …

Whole-body ultra-low dose CT using spectral shaping for detection of osteolytic lesion in multiple myeloma

S Suntharalingam, C Mikat, A Wetter, N Guberina… - European …, 2018 - Springer
Objectives The aim of this study was to investigate the radiation dose and image quality of a
whole-body low-dose CT (WBLDCT) using spectral shaping at 100 kV (Sn 100 kV) for the …

Development of a semiquantitative whole-body MRI scoring system for multiple myeloma

DK Kim, JY Jung, H Kim, S Lee, SY Lee, S Lee… - Radiology, 2023 - pubs.rsna.org
Background In patients with multiple myeloma (MM), the serum marker β2-microglobulin
does not always accurately reflect tumor load. In contrast, whole-body (WB) MRI has shown …

The Role of 18F‐FDG PET/CT in Multiple Myeloma Staging according to IMPeTUs: Comparison of the Durie–Salmon Plus and Other Staging Systems

S Deng, B Zhang, Y Zhou, X Xu, J Li… - Contrast Media & …, 2018 - Wiley Online Library
We aimed at comparing the Durie–Salmon Plus (DS Plus) staging system based on Italian
Myeloma criteria for PET USe (IMPeTUs) with other two staging systems in predicting …

Diagnostic performance of 18F-FDG PET/CT and whole-body MRI before and early after treatment of multiple myeloma: a prospective comparative study

MAA Basha, MAG Hamed, R Refaat… - Japanese Journal of …, 2018 - Springer
Objective To determine the diagnostic accuracy of WB-MRI and 18 F-FDG PET/CT in
detecting infiltration pattern, disease activity, and response to treatment in patients with …

Radiomics and artificial intelligence for outcome prediction in multiple myeloma patients undergoing autologous transplantation: a feasibility study with CT data

D Schenone, A Dominietto, C Campi, F Frassoni… - Diagnostics, 2021 - mdpi.com
Multiple myeloma is a plasma cell dyscrasia characterized by focal and non-focal bone
lesions. Radiomic techniques extract morphological information from computerized …

Optimization of whole-body 2-[18F]FDG-PET/MRI imaging protocol for the initial staging of patients with myeloma

R Burns, S Mulé, P Blanc-Durand, M Tofighi… - European …, 2022 - Springer
Objective To determine the optimal 2-[18 F] FDG-PET/MRI imaging protocol for the initial
staging of patients with suspected or confirmed multiple myeloma. Methods Radiologists …

[HTML][HTML] The status of jaw lesions and medication-related osteonecrosis of jaw in patients with multiple myeloma

SY Lu, MC Ma, MC Wang, SS Hsue - Journal of the Formosan Medical …, 2021 - Elsevier
Background/purpose Myeloma jaw lesions are not uncommon. The study aimed to
investigate the status of jaw lesions and medication-related osteonecrosis of jaw (MRONJ) …